Carol J. Wikstrand

Phase II Trial of Gefitinib in Recurrent Glioblastoma

Jeremy N. Rich, David A. Reardon, Terry Peery et al. · Journal of Clinical Oncology · 2003 · 726 citations · Full text

Mutant Epidermal Growth Factor Receptor (EGFRvIII) Contributes to Head and Neck Cancer Growth and Resistance to EGFR Targeting

John C. Sok, Francesca M Coppelli, Sufi M. Thomas et al. · Clinical Cancer Research · 2006 · 488 citations · Full text

Heterogeneity of Genotypic and Phenotypic Characteristics of Fifteen Permanent Cell Lines Derived from Human Gliomas

Darell D. Bigner, Sandra H. Bigner, Jan Pontén et al. · Journal of Neuropathology & Experimental Neurology · 1981 · 484 citations

Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas.

Carol J. Wikstrand, Laura P. Hale, Surinder K. Batra et al. · PubMed · 1995 · 470 citations

Specific Mabs, Specific Monoclonal Antibodies, Cancer Immunosurveillance +15

Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.

Mario A. Bourdon, Carol J. Wikstrand, Heinz Furthmayr et al. · PubMed · 1983 · 375 citations

Tumor Innervation, Immunology, Pathology +17